Shionogi & Co., Ltd. (OTCMKTS:SGIOF) Shares Up 4.9% – Should You Buy?

Shares of Shionogi & Co., Ltd. (OTCMKTS:SGIOF) were up 4.9% during mid-day trading on Thursday . The stock traded as high as $18.89 and last traded at $18.89. Approximately 1,560 shares changed hands during trading, an increase of 44% from the average daily volume of 1,080 shares. The stock had previously closed at $18.00.

Shionogi & Co., Ltd. Price Performance

The company has a fifty day moving average price of $16.64 and a two-hundred day moving average price of $17.05.

About Shionogi & Co., Ltd.

Shionogi & Co, Ltd. is a research-driven pharmaceutical company headquartered in Osaka, Japan, with origins dating back to 1878. The company concentrates on the discovery, development and sale of prescription medicines in key therapeutic areas, including infectious diseases, pain management, cardiovascular and metabolic disorders, central nervous system disorders and oncology. Shionogi’s mission emphasizes addressing unmet medical needs, particularly in the field of antimicrobial resistance, where it has developed both small-molecule antibiotics and novel treatment approaches.

The firm’s product portfolio comprises marketed therapies such as Cresemba (isavuconazole) for invasive fungal infections, and Fetroja (cefiderocol), a siderophore cephalosporin antibiotic for multidrug-resistant Gram-negative infections.